BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1725158)

  • 1. Metastatic prostatic adenocarcinoma-diagnosed by bronchoalveolar lavage and tumour marker determination.
    Verstraeten A; Sault MC; Wallaert B; Lemonnier P; Gosselin B; Tonnel AB
    Eur Respir J; 1991 Nov; 4(10):1296-8. PubMed ID: 1725158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Kozłowski M
    Neoplasma; 1992; 39(5):283-5. PubMed ID: 1331827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of prostatic adenocarcinoma with pulmonary metastases--diagnosis by transbronchial lung biopsy and immunohistochemistry].
    Nishi K; Amemiya T; Ooka T; Kurumaya H; Fujimaru M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):1001-5. PubMed ID: 7531254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of neuron specific enolase levels and squamous cell carcinoma antigen in bronchial lavage fluid in patients with lung cancer].
    Załteska J; Pirozyński M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1996; 64(1-2):11-8. PubMed ID: 8630459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult prostate adenocarcinoma with pulmonary metastasis: diagnosis by fine needle aspiration biopsy of the lung and immunohistochemistry.
    Chen LT; Tseng HH; Hwang WS
    Taiwan Yi Xue Hui Za Zhi; 1989 Sep; 88(9):940-2. PubMed ID: 2482856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The present role of prostatic specific antigen (PSA) as a tumor marker in carcinoma of the prostate.
    Parra RO
    Mo Med; 1991 Jun; 88(6):349-52. PubMed ID: 1712422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
    Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
    Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor marker in lung cancer].
    Shijubo N; Abe S
    Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
    [No Abstract]   [Full Text] [Related]  

  • 9. Metastatic carcinoma of the prostate mimicking primary carcinoid tumor of the lung and mediastinum.
    Anton RC; Schwartz MR; Kessler ML; Cagle PT
    Pathol Res Pract; 1998; 194(11):753-8. PubMed ID: 9842633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of prostate-specific antigen in the management of localized prostatic cancer.
    Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW
    Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV
    Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two cases of prostate cancer found primarily from lung metastatic lesions].
    Sugama Y; Uji M; Matsushita H
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):733-8. PubMed ID: 14584395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
    Svanholm H; Hørder M
    Scand J Urol Nephrol Suppl; 1988; 107():65-70. PubMed ID: 2453920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of the tumor markers CEA, SCC and NSE in serum and bronchoalveolar lavage].
    von Eiff M; Koch O; Appelhans N; Roos N; van de Loo J
    Pneumologie; 1990 Feb; 44 Suppl 1():462-4. PubMed ID: 2164198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
    Mulders TM; Bruning PF; Bonfrer JM
    Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic predictability of CEA and TPA tumor markers in bronchoalveolar lavage fluid].
    Loos U; Oehr P; Genske F; Schlack W
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():235-7. PubMed ID: 3174571
    [No Abstract]   [Full Text] [Related]  

  • 17. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA; Yang N; Hay AR; McNeal JE; Freiha FS; Redwine E
    N Engl J Med; 1987 Oct; 317(15):909-16. PubMed ID: 2442609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of determining the concentration of carcinoembryonic antigen in bronchial lavage for diagnosis of lung cancer].
    Załeska J; Pirozyński M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1995; 63(5-6):286-92. PubMed ID: 7581059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer.
    Nikliński J; Chyczewska E; Furman M; Kowal E; Laudanski J; Chyczewski L
    Neoplasma; 1993; 40(5):305-8. PubMed ID: 8272160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.